A Study of Olverembatinib in SDH-deficient GIST.
A Study of Olverembatinib in SDH-deficient GIST.
Recruiting · NCT06640361 · Registry updated 2026-07-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Olverembatinib in SDH-deficient GIST. | gastrointestinal stromal tumor | Recruiting | Phase 3 | 2026-07-23 | NCT06640361 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ascentage Pharma Group Inc. | 30 |
| HealthQuest Pharma Inc. | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-sen University Cancer Center | Guangzhou | China | 61 |